Negative-strand RNA viruses: applications to biotechnology (Q44721839)

5 December 2017

1 reference

title

Negative-strand RNA viruses: applications to biotechnology (English)

1 reference

5 December 2017

0 references

1

1 reference

5 December 2017

1 May 1998

1 reference

5 December 2017

Trends in Biotechnology

1 reference

5 December 2017

16

1 reference

5 December 2017

5

1 reference

5 December 2017

230-235

1 reference

Genetic manipulation of non-segmented negative-strand RNA viruses

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Genetic engineering of animal RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Negative-strand RNA viruses: genetic engineering and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Development of novel influenza virus vaccines and vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Introduction of site-specific mutations into the genome of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Infectious rabies viruses from cloned cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Recombinant vesicular stomatitis viruses from DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

An infectious clone of human parainfluenza virus type 3

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Recovery of infectious human parainfluenza virus type 3 from cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Rescue of measles virus using a replication-deficient vaccinia-T7 vector

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Normal replication of vesicular stomatitis virus without C proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Influenza virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Characterization ofin VivoPrimary and Secondary CD8+T Cell Responses Induced by Recombinant Influenza and Vaccinia Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Expression of a foreign protein by influenza A virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Highly stable expression of a foreign gene from rabies virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

A CXCR4/CD4 Pseudotype Rhabdovirus That Selectively Infects HIV-1 Envelope Protein-Expressing Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2898%2901192-5

7 January 2021

10.1016/S0167-7799(98)01192-5

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

9621463